Shearman & Sterling advised Bank of America, N.A. as Administrative Agent on an amendment and restatement of Viatris Inc.’s existing $4 billion senior unsecured revolving credit facility to finance general corporate purposes.

Viatris Inc., a healthcare company, develops, licenses, manufactures, markets, and distributes brand and generic drugs, complex generics, biosimilars, and active pharmaceutical ingredients (APIs) worldwide. The company operates through Developed Markets, Greater China, JANZ, and Emerging Markets segments.

The Team